The vasoactive role of nitric oxide: Physiological and morphological aspects

Current Pharmaceutical Biotechnology

Volumn 12, Issue 9, 2011, Pages 1294-1304

  Cacanyiova, Sona ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Conduit artery; Contraction; Nitric oxide; NO synthase; Relaxation; Vascular smooth muscle

Indexed keywords

ADRENERGIC RECEPTOR; ANGIOTENSIN 1 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN B RECEPTOR; HISTAMINE H1 RECEPTOR; MUSCARINIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTICLE; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR FUNCTION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HYPERTENSION; NONHUMAN; OXIDATIVE STRESS; PRESSORECEPTOR; PROTEIN EXPRESSION; RECEPTOR BINDING; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION;

EID: 80052254263     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111798280992     Document Type: Article

References (141)

1. Furchgott, R.F.; Zawadski, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288, 373-376.
2. Furchgott, R.F. The discovery of endothelium-dependent relaxation. Circulation, 1993, 87(Suppl V), V3-V8.
3. Ignarro, L.J.; Buga, G.M.; Wood, K.S.; Byrns, R.E.; Chaudhury, G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA, 1987, 84, 9265-9269.
4. Haller, H. Hypertension, the endothelium and pathogenesis of chronic vascular disease. Kidney Blood Press. Res., 1996, 19(3-4), 166-171.
5. Kunes, J.; Hojna, S.; Kadlecova, M.; Dobesova, Z.; Rauchova, H.; Vokurkova, M.; Loukotova, J.; Pechanova, O.; Zicha, J. Altered balance of vasoactive systems in experimental hypertension: the role of relative NO deficiency. Physiol. Res., 2004, 53 (Suppl 1), S23-S34.
6. Dananberg, J.; Sider, R.S.; Grekin, R.J. Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension, 1993, 21(3), 359-363.
7. Pechanova, O.; Bernatova, I. Effect of long-term NO synthase inhibition on cyclic nucleotide content in rat tissues. Physiol. Res., 1996, 45(4), 305-309.
8. Holecyova, A.; Torok, J.; Bernatova, I.; Pechanova, O. Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension. Physiol. Res., 1996, 45(4), 317-321.
9. Moncada, S. Nitric oxide. J. Hypertens., 1994, 12(10), S35-S39.
10. Wennmalm, A. Endothelial nitric oxide and cardiovascular disease. J. Intern. Med., 1994, 235(4), 317-327.
11. Rubanyi, G.M.; Vanhoutte, P.M. Heterogeneity of endotheliumdependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells. Blood Vessels, 1988, 25(2), 75-81.
12. Gao, Y.; Zhou, H.; Raj, J.U. Endothelium-derived nitric oxide plays a larger role in pulmonary veins than in arteries of newborn lambs. Circ. Res., 1995, 76(4), 559-565.
13. Laughlin, M.H.; Turk, J.R.; Schrage, W.G.; Woodman, C.R.; Price, E.M. Influence of coronary artery diameter on eNOS protein content. Am. J. Physiol., 2003, 284(4), H1307-H1312.
14. Kimura, C.; Oike, M.; Ohnaka, K.; Nose, Y.; Ito, Y. Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study. J. Physiol., 2004, 554(Pt 3), 721-730.
15. Busse, R.; Mulsch, A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett., 1990, 265(1-2), 133-136.
16. Palmer, R.M.; Ashton, D.S.; Moncada, S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 1988, 333(6174), 664-666.
17. Rapoport, R.M.; Murad, F. Agonist-induced endotheliumdependent relaxation in rat thoracic aorta may be mediated through cGMP. Circ. Res., 1983, 52(3), 352-357.
18. Deuchar, G.A.; Docherty, A.; MacLean, M.R.; Hicks, M.N. Pulmonary hypertension secondary to left ventricular dysfunction: the role of nitric ixide and endothelin-1 in the control of pulmonary vascular tone. Br. J. Pharmacol., 2002, 135(4), 1060-1068.
19. Nguyen, T.D.; Vequaud, P.; Thorin, E. Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alphaadrenergic-dependent contractions of rabbit resistance arteries. Cardiovasc.Res., 1999, 43(3), 755-761.
20. Berkenboom, G.; Unger, P.; Fang, Z.Y.; Fontaine, J. Endotheliumderived relaxing factor and protection against contraction to norepinephrine in isolated canine and human coronary arteries. J. Cardiovasc. Pharmacol., 1991, 17, S127-S132.
21. Vo, P.A.; Reid, J.J.; Rand, M.J. Endothelial nitric oxide attenuates vasoconstrictor responses to nerve stimulation and noradrenaline in the rat tail artery. Eur. J. Pharmacol., 1991, 199(1), 123-125.
22. Tesfamariam, B.; Weisbrod, R.M.; Cohen, R.A. Endothelium inhibits responses of rabbit carotid artery to adrenergic nerve stimulation. Am. J. Physiol., 1987, 253 (22), H792-H798.
23. Toda, N.; Okamura, T. Modification by L-NG-monometyl arginine (L-NMMA) of the response to nerve stimulation in isolated dog mesenteric and cerebral arteries. Japan. J. Pharmacol., 1990, 52(1), 170-173.
24. Kysela, S.; Torok, J. The role of endothelial nitric oxide in neurogenic contractions of rabbit carotid artery during cooling. Bratisl. Lek. Listy, 1997, 98(2), 80-85.
25. Segarra, G.; Medina, P.; Revert, F.; Masia, S.; Vila, J.M.; Such, L.; Aldasoro, M. Modulation of adrenergic contraction of dog pulmonary arteries by nitric oxide and prostacyclin. Gen. Pharmac., 1999, 32(5), 583-589.
26. Torok, J.; Kristek, F. Functional and morphological pattern of vascular responses in two models of experimental hypertension. Exp. Clin. Cardiol., 2001, 6(3), 142-148.
27. Mulsch, A.; Bassenge, E.; Busse, R. Nitric oxide synthesis in endothelial cytosol: evidence for a calcium-dependent and calciumindependent mechanism. Naunyn Schmiedeberg's Arch. Pharmacol., 1989, 340(6 Pt 2), 767-770.
28. Presta, A.; Liu, J.; Sessa, W.C.; Stuehr, D.J. Substrate binding and calmodulin binding to endothelial nitric oxide synthase coregulate its enzymatic activity. Nitric Oxide, 1997, 1(1), 74-87.
29. Pohl, U.; Holtz, J.; Busse, R.; Bassenge, E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension, 1986, 8(1), 37-44.
30. Smiesko, V.; Kozík, J.; Dolezel, S. Role of endothelium in the control of arterial diameter by blood flow. Blood Vessels, 1985, 22(5), 247-251.
31. Melkumyants, A.M.; Balshov, S.A.; Veselova, E.S.; Khayutin, V.M. Continuous control of the lumen of feline conduit arteries by blood flow rate. Cardiovasc. Res., 1987, 21(12), 863-870.
32. Smiesko, V.; Lang, D.J.; Johnson, P.C. Dilator response of rat mesenteric arcading arterioles to increased blood flow velocity. Am. J. Physiol., 1989, 257(6 Pt 2), H1958-H1965.
33. Kuo, L.; Chilian, W.M.; Davis, M.J. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol., 1991, 261(6 Pt 2), H1706-H1715.
34. Bossaller, C.; Habib, G.B.; Yamamoto, H.; Williams, C.; Wells, S.; Henry, P.D. Impaired muscarinic endothelium-dependent relaxation and cyclic guanosine 5'-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest., 1987, 79(1), 170-174.
35. Searle, N.R.; Sahab, P. Endothelial vasomotor regulation in health and disease. Can. J. Anaesth., 1992, 39(8), 838-857.
36. Kysela, S.; Torok, J. Histamine H1-receptor antagonists do not prevent the appearance of endothelium-dependent relaxation to acetylcholine in rat pulmonary artery. Physiol. Res., 1996, 45(4), 345-350.
37. Krstic, M.K.; Stepanovic, R.M.; Krstic, S.K.; Katusic, Z.S. Endothelium- dependent relaxation of the rat renal artery caused by activation of histamine H1-receptors. Pharmacology, 1989, 38(2), 113-120.
38. Kysela, S.; Torok, J. Contemporary activation of different endothelial receptors accounts for a reserve mechanism of nitric oxidemediated relaxation. Physiol. Res., 2000, 49(1), 115-122.
39. Garcia-Villalon, A.L.; Monge, L.; Montoya, J.J.; Garcia, J.L.; Fernandez, N.; Gomez, B.; Dieguez, G. Cooling and response to adrenoceptor agonists of rabbit ear and femoral artery: role of the endothelium. Brit. J. Pharmacol., 1992, 106(3), 727-732.
40. Kristek, F.; Torok, J.; Sikulova, J. Morphological and functional alterations in endothelium, smooth muscle, and nerve fibers in rabbit aorta after storage at 4 degrees oC. Cryobiology, 1993, 30(4), 376-385.
41. Torok, J.; Kristek, F.; Mokrasova, M. Endothelium-dependent relaxation in rabbit aorta after cold storage. Eur. J. Pharmacol., 1993, 228(5-6), 313-319.
42. Karaki, H.; Nagase, H. Low temperature augments the endothelium- dependent relaxation in isolated rat aorta. Eur. J. Pharmacol., 1987, 142(1),129-132.
43. Ding, H.; Triggle, C.R. Novel endothelium-derived relaxing factors. Identification of factors and cellular targets. J. Pharmacol. Toxicol. Methods, 2000, 44(2), 441-452.
44. Harris, D.; Martin, P.E.; Evans, W.H.; Kendall, D.A.; Griffith, T.M.; Randall, M.D. Role of gap junctions in endothelium-derived hyperpolarizing factor responses and mechanisms of K(+)- relaxation. Eur. J. Pharmacol., 2000, 402(1-2), 119-128.
45. + channels. Circulation, 1999, 99(24), 3132-3138.
46. Azevedo, L.C.; Pedro, M.A.; Souza, L.C.; de Souza, H.P.; Janiszewski, M.; da Luz, P.L.; Laurindo, F.R. Oxidative stress as a signaling mechanism of the vascular response to injury: the redox hypothesis of restenosis. Cardiovasc. Res., 2000, 47(3), 436-445.
47. Souza, H.P.; Souza, L.C.; Anastacio, V.M.; Pereira, A.C.; Junqueira, M.L.; Krieger, J.E.; da Luz, P.L.; Augusto, O.; Laurindo, F.R. Vascular oxidant stress early after balloon injury: evidence for increased NAD(P)H oxidoreductase activity. Free Radical Bio. Med., 2000, 28(8), 1232-1242.
48. Ozel, S.K.; Yuksel, M.; Haklar, G.; Durakbasa, C.U.; Dagli, T.E.; Aktan, A.O. Nitric oxide and endothelin relationship in intestinal ischemia/reperfusion injury (II). Prostag. Leukotr. Ess., 2001, 64(4-5), 253-257.
49. Rieger, J.M.; Shah, A.R.; Gidday, J.M. Ischemia-reperfusion injury of retinal endothelium by cyclooxygenase-and xanthine oxidasederived superoxide. Exp. Eye Res., 2002, 74(4), 493-501.
50. Erdogan, H.; Fadillioglu, E.; Emre, M.H. Protection from renal ischemia reperfusion injury by an endothelin-A receptor antagonist BQ-123 in relation to nitric oxide production. Toxicology, 2006, 228(2-3), 219-228.
51. Linas, S.L.; Repine, J.E. Endothelial cells protect vascular smooth muscle cells from H2O2 attack. Am. J. Physiol., 1997, 272(6 Pt 2), F767-F773.
52. Walia, M.; Sormaz, L.; Samson, S.E.; Lee, R.M.; Grover, A.K. Effects of hydrogen peroxide on pig coronary artery endothelium. Eur. J. Pharmacol., 2000, 400(2-3), 249-253.
53. Buchwalow, I.B.; Podzuweit, T.; Samoilova, V.E.; Wellner, M.; Haller, H.; Grote, S.; Aleth, S.; Boecker, W.; Schmitz, W.; Neumann, J. An in situ evidence for autocrine function of NO in the vasculature. Nitric Oxide, 2004, 10(4), 203-212.
54. Buchwalow, I.B.; Podzuweit, T.; Bocker, W.; Samoilova, V.E.; Thomas, S.; Wellner, M.; Baba, H.A.; Robenek, H.; Schnekenburger, J.; Lerch, M.M. Vascular smooth muscle and nitric oxide synthase. FASEB J., 2002, 16(6), 500-508.
55. Gaudino, M.; Toesca, A.; Maggiano, N.; Pragliola, C.; Possati, G. Localization of nitric oxide synthase III in the internal thoracic and radial arteries and the great saphenous vein: A comparative immunohistochemical study. J. Thorac. Cardiovasc. Surg., 2003, 125(6), 1510-1515.
56. Schwarz, P.M.; Kleinert, H.; Forstermann, U. Potential functional significance of brain-type and muscle-type nitric oxide synthase I expressed in adventitia and media of rat aorta. Arterioscler. Thromb. Vasc. Biol., 1999, 19(11), 2584-2590.
57. Brophy, C.M.; Knoepp, L.; Xin, J.; Pollock, J.S. Functional expression of NOS 1 in vascular smooth muscle. Am. J. Physiol. Heart circ. Physiol., 2000, 278(3), H991-H997.
58. Cheah, L.S.; Gwee, M.; Das, R.; Ballard, H.; Yang, Y.F.; Daniel, E.E.; Kwan, C.Y. Evidence for the existence of a constitutive nitric oxide synthase in vascular smooth muscle. Clin. Exp. Pharmacol. P., 2002, 29(8), 725-727.
59. Charpie, J.R.; Webb, R.C. Vascular myocyte-derived nitric oxide is an autocrine that limits vasoconstriction. Biochem. Biophys. Res. Commun., 1993, 194(2), 763-768.
60. Boulanger, C.M.; Heymes, C.; Benessiano, J.; Geske, R.S.; Levy, B.I.; Vanhoutte, P.M. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells: activation by angiotensin II in hypertension. Circ. Res., 1998, 83(12), 1271-1278.
61. Napoli, C.; Ignarro, L.J. Nitric oxide and atherosclerosis. Nitric Oxide, 2001, 5(2), 88-97.
62. Zhao, W.; Swanson, S.A.; Ye, J.; Li, X.; Shelton, J.M.; Zhang, W.; Thomas, G.D. Reactive oxygen species impair sympathetic vasoregulation in skeletal muscle in angiotensin II-dependent hypertension. Hypertension, 2006, 48(4), 637-643.
63. Just, A.; Whitten, C.L.; Arendshorst, W.J. Reactive oxygen species participate in acute renal vasoconstrictor responses induced by ETA and ETB receptors. Am. J. Physiol., 2008, 294(4), F719-F728.
64. Lee, M.Y.; Griendling, K.K. Redox signaling, vascular function, and hypertension. Antioxid. Redox Sign., 2008, 10(6), 1045-1059.
65. Buchwalow, I.B.; Cacanyiova, S.; Neumann, J.; Samoilova, V.E.; Boecker, W.; Kristek, F. The role of arterial smooth muscle in vasorelaxation. Biochem. Biophys. Res. Commun., 2008, 377(2), 504-507.
66. Seraya, I.P.; Nartsissov, Y.R. Theoretical approach to description of time-dependent nitric oxide effects in the vasculature. Mol. Biol. Rep., 2002, 29(1-2), 151-155.
67. Duckles, S.P. Vascular muscarinic receptors: pharmacological characterization in the bovine coronary artery. J. Pharmacol. Exp. Ther., 1988, 246(3), 929-934.
68. Lincoln, T.M. Cyclic GMP and mechanisms of vasodilation. Pharmacol. Ther., 1989, 41(3), 479-502.
69. Beall, A.C.; Kato, K.; Goldenring, J.R.; Rasmusen, H.; Brophy, C.M. Cyclic nucleotide- dependent vasorelaxation is associated with the phosphorylation of a small heat shock-related protein. J. Biol. Chem., 1997, 272(17), 11283-11287.
70. Beall, A.; Bagwell, D.; Woodrum, D.; Stoming, T.A.; Kato, K.; Suzuki, A.; Rasmussen, H.; Brophy, C.M. The small heat shockrelated protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation. J. Biol. Chem., 1999, 274(16), 11344-11351.
71. Liang, P.; MacRae, T.H. Molecular chaperones and the cytoskeleton. J. Cell. Sci., 1997, 110(Pt 13), 1431-1440.
72. Brophy, C.M.; Lamb, S.; Graham, A. The small heat shock-related protein-20 is an actin-associated protein. J. Vasc. Surg., 1999, 29(2), 326-333.
73. Beall, A.; Bagwel, D.; Woodrum, D.; Stoming, T.A.; Kato, K.; Suzuki, A.; Rasmussen, H.; Brophy, C.M. The small heat shockrelated protein, HSP20, is phosphorylated on serine 16 during cyclic nucleotide-dependent relaxation. J. Biol. Chem., 1999, 274(16), 11344-11351.
74. Van Hove, C.E.; Van der Donckt, C.; Herman, A.G.; Bult, H.; Fransen, P. Vasodilator efficacy of nitric oxide depends on mechanisms of intracellular calcium mobilization in mouse aortic smooth muscle cells. Br. J. Pharmacol., 2009, 158(3), 920-930.
75. Ishine, T.; Miyuachi, Y.; Uchida, M.K. Calcium(++)-independent relaxation mediated by beta adrenoceptor in calcium(++)-independent contraction of uterine smooth muscle. J. Pharmacol. Exp. Ther., 1993, 266(1), 367-373.
76. Brophy, C.M.; Whitney, E.G.; Lamb, S.; Beall, A. Cellular mechanisms of cyclic nucleotide-iduced vasorelaxation. J. Vasc. Surg., 1997, 25(2), 390-397.
77. Throckmorton, D.C.; Packer, C.S.; Brophy, C.M. Protein kinase C activation during Ca2+-independent vascular smooth muscle contraction. J. Surg. Res., 1998, 78(1), 48-53.
78. Forstermann, U.; Nakane, M.; Tracey, W.R.; Pollock, J.S. Isoforms of nitric oxide synthase: functions in the cardiovascular system. Eur. Heart J., 1993, 14(Suppl. I), 10-15.
79. Pollock, J.S.; Nakane, M.; Buttery, L.D.; Martinez, A.; Springall, D.; Polak, J.M.; Forstermann, U.; Murad, F. Characterization and localization of endothelial nitric oxide synthase using specific monoclonal antibodies. Am. J. Physiol., 1993, 265(5 Pt 1), C1379-C1387.
80. Bredt, D.S.; Hwang, P.M.; Snyder, S.H. Localisation of nitric oxide synthase indicating a neuronal role for nitric oxide. Nature, 1990, 347(6295), 768-770.
81. Davisson, R.L.; Possas, O.S.; Murphy, S.P.; Lewis, S.J. Neurogenically derived nitrosyl factors mediate sympathetic vasodilation in the hindlimb of the rat. Am. J. Physiol., 1997, 272(5 Pt 2), H2369-H2376.
82. Loesch, A.; Burnstock, G. Perivascular nerve fibres and endothelial cells of the rat basilar artery: immuno-gold labelling of antigenic sites for type I and type III nitric oxide synthase. J. Neurocytol, 1998, 27(3), 197-204.
83. Bachetti, T.; Comini, L.; Curello, S.; Bastianon, D.; Palmieri, M.; Bresciani, G.; Callea, F.; Ferrari, R. Co-expression and modulation of neuronal and endothelial nitric oxide synthase in human endothelial cells. J. Mol. Cell. Cardiol., 2004, 37(5), 939-945.
84. Danson, E.J.; Choate, J.K.; Paterson, D.J. Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol. Ther., 2005, 106(1), 57-74.
85. Mundel, P.; Bachmann, S.; Bader, M.; Fisher, A.; Kummer, W.; Mayer, B.; Kriz, W. Expression of nitric oxide synthase in kidney macula densa cells. Kidney Int., 1992, 42(4), 1017-1019.
86. Tojo, A.; Kimoto, M.; Wilcox, C.S. Renal expression of constitutive NOS and DDAH: separate effect of salt intake and angiogenesis. Kidney Int., 2000, 58(5), 2075-2083.
87. Mount, P.F.; Fraser, S.A.; Watanabe, Y.; Lane, N.; Katsis, F.; Chen, Z.P.; Kemp, B.E.; Power, D.A. Phosphorylation of neuronal and endothelial nitric oxide synthase in the kidney with high and low salt diets. Nephron Physiol., 2006, 102(2), 36-50.
88. Arnal, J.F.; Warin, L.; Michel, J.B. Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. J. Clin. Invest., 1992, 90(2), 647-652.
89. Ribeiro, M.O.; Antunes, E.; DeNucci, G.; Lovisolo, S.M.; Zatz, R. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension. Hypertension, 1992, 20(3), 298-303.
90. Ruiz-Marcos, F.M.; Ortíz, M.C.; Fortepiani, L.A.; Nadal, F.J.; Atucha, N.M.; Garcia-Estao, J. Mechanisms of the increased pressor response to vasopressor in the mesenteric bed of nitric oxidedeficient hypertensive rats. Eur. J. Pharmacol., 2001, 412(3), 273-279.
91. Bernatova, I.; Pechanova, O.; Babal, P.; Kysela, S.; Stvrtina, S.; Andriantsitohaina, R. Wine polyphenos improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am. J. Physiol., 2002, 282(3), H942-H948.
92. Pechanova, O.; Bernatova, I.; Babal, P.; Martinez, M.C.; Kysela, S.; Stvrtina, S.; Andriantsitohaina, R. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J. Hypertens., 2004, 22(8), 1551-1559.
93. Li, J.S.; Schiffrin, E.L. Resistance artery structure and neuroeffector mechanisms in hypertension induced by inhibition of nitric oxide synthase. Am. J. Hypertens., 1994, 7(11), 996-1004.
94. Kristek, F.; Gerova, M.; Devat, L.; Varga, I. Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats. Physiol. Res., 1996, 45 (4), 329-333.
95. Babal, P.; Pechanova, O.; Bernatova, I.; Stvrtina, S. Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histol. Histopathol., 1997, 12(3), 623-629.
96. Pechanova O.; Bernatova, I.; Pelouch, V.; Simko, F. Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. J. Mol. Cell Cardiol., 1997, 29 (12), 3365-3374.
97. Tomita, H.; Egashira, K.; Ohara, Y.; Takemoto, M.; Koyanagi, M.; Katoh, M.; Yamamoto, H.; Tamaki, K.; Shimokawa, H.; Takeshita, A. Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats. Hypertension, 1998, 32(2), 273-279.
98. Kitamoto, S.; Egashira, K.; Kataoka, C.; Koyanagi, M.; Katoh, M.; Shimokawa, H.; Morishita, R.; Kaneda, Y.; Sueishi, K.; Takeshita, A. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Circulation, 2000, 102(7), 806-812.
99. Rudic, R.D.; Shesely, E.G.; Maeda, N.; Smithies, O.; Segal, S.S.; Sessa, W.C. Direct evidence for the importance of endotheliumderived nitric oxide in vascular remodeling. J. Clin. Invest., 1998, 101(4), 731-736.
100. Kalliovalkama, J.; Jolma, P.; Tolvanen, J.P.; Kahonen, M.; Hutri-Kahonen, N.; Wu, X.; Holm, P.; Porsti, I. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism. Cardiovasc. Res., 1999, 42(3), 773-782.
101. Kopkan, L.; Majid, D.S. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats. Hypertension, 2006, 47(3), 568-572.
102. Kojsova, S.; Jendekova, L.; Zicha, J.; Kunes, J.; Andriantsitohaina, R.; Pechanova, O. The effect of different antioxidants on nitric oxide production in hypertensive rats. Physiol. Res., 2006, 55(Suppl 1), S3-16.
103. Bernatova, I.; Pechanova, O.; Simko, F. Effect of captopril in LNAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp. Physiol., 1999, 84(6), 1095-1105.
104. Jover, B.; Mimran, A. Nitric oxide inhibition and renal alterations. J. Cardiovasc. Pharmacol., 2001, 38 (Suppl 2), S65-S70.
105. Hirooka, Y.; Polson, J.W.; Dampney, R.A. Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medulla. J. Hypertens., 1996, 14(11), 1317-1324.
106. Paulis, L.; Zicha, J.; Kunes, J.; Hojna, S.; Behuliak, M.; Celec, P.; Kojsova, S.; Pechanova, O.; Simko, F. Regression of L-NAMEinduced hypertension: the role of nitric oxide and endotheliumderived constricting factor. Hypertens. Res., 2008, 31(4), 793-803.
107. Kristek, F. Pentaerythrityl tetranitrate could prevent structural changes in conduit arteries evoked by long-term NO-synthase inhibition. Br. J. Pharmacol., 2000, 130(2), 450-456.
108. Torok, J.; Kristek, F. Beneficial effect pentaerythrityl tetranitrate on functional and morphological changes in the rat thoracic aorta evoked by long-term nitric oxide synthase inhibition. Vasc. Pharmacol., 2002, 38(3), 177-182.
109. Moore, P.K.; Wallace, P.; Gaffen, Z.; Hart, S.L.; Babbedge, R.C. Characterisation of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br. J. Pharmacol., 1993, 110(1), 219-224.
110. Yoshida, T.; Limmroth, V.; Irikura, K.; Moskowitz, M.A. The NOS inhibitor, 7-nitroindazole, decreases focal infarct volume but not the response to topical acetylcholine in pial vessels. J. Cereb. Blood. Flow. Metab., 1994, 14(6), 924-929.
111. Wangensteen, R.; Sainz, J.; Rodriguez-Gomez, I.; Moreno, J.M.; Osuna, A.; Vargas, F. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone-treated rats. Exp. Physiol., 2003, 88(2), 243-250.
112. Wangensteen, R.; Rodriguez-Gomez, I.; Moreno, J.M.; Alvarez-Guerra, M.; Osuna, A.; Vargas, F. Effects of chronic treatment with 7-nitroindazole in hyperthyroid rats. Am. J. Physiol., 2006, 291(5), R1376-R1382.
113. Zagvazdin, Y.; Sancesario, G.; Wang, X.Y.; Share, L.; Fitzgerald, M.E.C.; Reiner, A. Evidence from its cardiovascular effects that 7-nitroindazole may inhibit endothelial nitric oxide synthase in vivo. Eur. J. Pharmacol., 1996, 303, 61-69.
114. Zagvazdin, Y.; Sancesario, G.; Fitzgerald, M.E.C.; Reiner, A. Effects of halothane and urethane-chlorase anaesthesia on the pressor and cerebrovascular responses to 7-NITROINDAZOLE, an inhibitor of nitric oxide synthase. Pharmacol. Res., 1998, 38 (5), 339-346.
115. Ollerstam, A.; Pittner, J.; Persson, A.E.; Thorup, C. Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase. J. Clin. Invest., 1997, 99(9), 2212-2218.
116. Cacanyiova, S.; Kristek, F.; Gerova, M.; Krenek, P.; Klimas, J. Effect of chronic nNOS inhibition on blood pressure, vasoactivity, and arterial wall structure in Wistar rats. Nitric Oxide, 2009, 20(4), 304-310.
117. Kristek, F.; Cacanyiova, S.; Gerova, M. Hypotrophic effect of long-term neuronal NO-synthase inhibition on heart and conduit arteries of the Wistar rats. J. Physiol. Pharmacol., 2009, 60(2), 21-27.
118. Gerova, M. Acetylcholine and bradykinin induce paradoxically amplified hypotensive response in hypertensive NO-deficient rats. Physiol. Res., 1999, 48(4), 249-257.
119. Luksha, L.; Agewall, S.; Kublickiene, K. Endothelium-derived hyperpolarizing factor in vascular physiology and cardiovascular disease. Atherosclerosis, 2009, 202(2), 330-344.
120. Benyo, Z.; Lacza, Z.; Hortobagyi, T.; Gorlach, C.; Wahl, M. Functional importance of neuronal nitric oxide synthase in the endothelium of rat basilar arteries. Brain Res., 2000, 877(1), 79-84.
121. Ayajiki, K.; Fujioka, H.; Okamura, T.; Toda, N. Relatively selective neuronal nitric oxide synthase inhibition by 7-nitroindazole in monkey isolated cerebral arteries. Eur. J. Pharmacol., 2001, 423(2-3), 179-183.
122. Nangle, M.R.; Cotter, M.A.; Cameron, N.E. An in vitro investigation of aorta and corpus cavernosum from eNOS and nNOS genedeficient mice. Pflugers Arch., 2004, 448(2), 139-145.
123. Wolff, D.J.; Lubeskie, A.; Umansky, S. The inhibition of the constitutive bovine endothelial nitric oxide synthase by imidazole and indazole agents. Arch. Biochem. Biophys., 1994, 314(2), 360-366.
124. Bernatova, I.; Kopincova, J.; Puzserova, A.; Janega, P.; Babal, P. Chronic low-dose L-NAME treatment increases nitric oxide production and vasorelaxation in normotensive rats. Physiol. Res., 2007, 56(Suppl 2), S17-S24.
125. Qadri, F.; Carretero, O.A.; Scicli, A.G. Centrally produced neuronal nitric oxide in the control of baroreceptor reflex sensivity and blood pressure in normotensive and spontaneously hypertensive rats. Japan. J. Pharmacol., 1999, 81(3), 279-285.
126. Kantzides, A.; Badoer, E. NNOS-containing neurons in the hypothalamus and medulla project to the RVLM. Brain Res., 2005, 1037(1-2), 25-34.
127. Wu, W.C.; Wang, Y.; Su, C.K.; Chai, C.Y. The nNOS/cGMP signal transducing system is involved in the cardiovascular responses induced by activation of NMDA receptors in the rostral vantrolateral medulla of cats. Neurosci. Lett., 2001, 310(2-3), 121-124.
128. Chan, S.H.; Wang, L.L.; Wang, S.H.; Chan, J.Y. Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rat. Br. J. Pharmacol., 2001, 133(4), 606-614.
129. Rabelo, F.A.; Russo, E.M.; Salgado, M.C.; Coelho, E.B. Nonendothelial NO blunts sympathetic response of normotensive rats but not of SHR. Hypertension, 2001, 38(3 Pt 2), 565-568.
130. Hatanaka, Y.; Hobara, N.; Honghua, J.; Akiyama, S.; Nawa, H.; Kobayashi, Y.; Takayama, F.; Gomita, Y.; Kawasaki, H. Neuronal nitric-oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J. Pharmacol. Exp. Ther., 2006, 316(2), 490-497.
131. Kurihara, N.; Alfie, M.E.; Sigmon, D.H.; Rhaleb, N.E.; Shesely, E.G.; Carretero, O.A. Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension, 1998, 32(5), 856-861.
132. Beierwaltes, W.H. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am. J. Physiol., 1997, 272(5 Pt 2), R1359-R1364.
133. Paliege, A.; Mizel, D.; Medina, C.; Pasumarthy, A.; Huang, Y.G.; Bachmann, S.; Briggs, J.P.; Schnermann, J.B.; Yang, T. Inhibition of nNOS expression in the macula densa by COX-2-derived prostaglandin E(2). Am. J. Physiol., 2004, 287(1), F152-F159.
134. Grumbach, I.M.; Chen, W.; Mertens, S.A.; Harrison, D.G. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J. Mol. Cell. Cardiol., 2005, 39(4), 595-603.
135. Beierwaltes, W.H. Selective neuronal nitric oxide synthase inhibition blocks furosemide-stimulated renin secretion in vivo. Am. J. Physiol., 1995, 269(1 Pt 2), F134-F139.
136. Ollerstam, A.; Skott, O.; Ek, J.; Persson, A.E.; Thorup, C. Effects of long-term inhibition of neuronal nitric oxide synthase on blood pressure and rennin release. Acta Physiol. Scand., 2001, 173(4), 351-358.
137. Ollerstam, A.; Persson A.E. Macula densa neuronal nitric oxide synthase. Cardiovasc. Res., 2002, 56(2), 189-196.
138. Koprdova, R.; Cebova, M.; Kristek, F. Long-term effect of losartan administration on blood pressure, heart and structure of coronary artery of young spontaneously hypertensive rats. Physiol. Res., 2009, 58(3), 327-335.
139. Gohlke, P.; Unger, T. Chronic low-dose treatment with perindopril improves cardiac function in stroke-prone spontaneously hypertensive rats by potentiation of endogenous bradykinin. Am. J. Cardiol., 1995, 76(15), 41E-45E.
140. Naftilan, A.J. The role of angiotensin II in vascular smooth muscle cell growth. J. Cardiovasc. Pharmacol., 1992, 20(Suppl 1), S37-S40.
141. Liu, J.L.; Murakami, H.; Zucker, I.H. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ. Res., 1998, 82(4), 469-502.